Patents by Inventor Clare L. Jones

Clare L. Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120189547
    Abstract: The present invention provides radiofluorinated compounds useful for in vivo imaging GABAA receptors. Also provided by the present invention is a method of synthesis for the radiofluorinated compounds of the invention, in particular an automated method of synthesis. A further aspect of the invention is a cassette suitable for carrying out the automated method of synthesis of the invention.
    Type: Application
    Filed: October 8, 2010
    Publication date: July 26, 2012
    Inventors: John Woodcraft, Clare L. Jones, Alessandra Gaeta, William John Trigg, Paul Alexander Jones, Stuart Plant
  • Patent number: 8158804
    Abstract: The present invention relates to chelating agents, in particular to chelating agents which are capable of forming complexes with paramagnetic metal ions such as iron (III) and gadolinium (III). The invention also relates to the complexes formed and their use as MRI contrast agents.
    Type: Grant
    Filed: January 11, 2008
    Date of Patent: April 17, 2012
    Assignee: GE Healthcare AS
    Inventors: Harry John Wadsworth, Ian Martin Newington, Clare L. Jones, Amanda Ewan, Dennis O'Shea
  • Publication number: 20100056787
    Abstract: The present invention relates to chelating agents, in particular to chelating agents which are capable of forming complexes with paramagnetic metal ions such as iron (III) and gadolinium (III). The invention also relates to the complexes formed and their use as MRI contrast agents.
    Type: Application
    Filed: January 11, 2008
    Publication date: March 4, 2010
    Applicant: GE Healthcare AS
    Inventors: Harry John Wadsworth, Ian Martin Newington, Clare L. Jones, Amanda Ewan, Dennis O'Sheo
  • Publication number: 20100008864
    Abstract: The present invention relates to novel compounds of formula (I) and (II), compositions comprising compounds of formula (II) and their use as contrast agents in magnetic resonance (MR) imaging (MRI) and MR spectroscopy (MRS).
    Type: Application
    Filed: July 8, 2009
    Publication date: January 14, 2010
    Inventors: Andreas Meijer, Harry John Wadsworth, Ian Martin Newington, Clare L. Jones, Amanda Ewan, Dennis O'Shea, Oskar Axelsson, Anders Brathe, Andreas Olsson, John Henrik Johansen, Duncan George Wynn